Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

  • Filters activated: AIDS. Clear all to show 134 items.
1.

Pneumocystis jirovecii infection of bilateral adrenal glands in an immunocompetent adult: a case report.

Sharma N, Ahlawat RS, Singh H, Sharma C, Anuradha S.

J R Coll Physicians Edinb. 2019 Sep;49(3):222-224. doi: 10.4997/JRCPE.2019.310.

PMID:
31497790
2.

Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis.

Eddens T, Elsegeiny W, Ricks D, Goodwin M, Horne WT, Zheng M, Kolls JK.

mSphere. 2019 Sep 4;4(5). pii: e00488-19. doi: 10.1128/mSphere.00488-19.

3.

Fungal Diseases in Taiwan-National Insurance Data and Estimation.

Huang YS, Denning DW, Shih SM, Hsiung CA, Wu UI, Sun HY, Chen PY, Chen YC, Chang SC.

J Fungi (Basel). 2019 Aug 21;5(3). pii: E78. doi: 10.3390/jof5030078.

4.

Estimated Burden of Fungal Infections in Namibia.

Dunaiski CM, Denning DW.

J Fungi (Basel). 2019 Aug 16;5(3). pii: E75. doi: 10.3390/jof5030075.

5.

Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.

Hammarström H, Grankvist A, Broman I, Kondori N, Wennerås C, Gisslen M, Friman V.

BMC Infect Dis. 2019 Jul 23;19(1):658. doi: 10.1186/s12879-019-4289-4.

6.

The Burden of Serious Fungal Infections in Kyrgyzstan.

Turdumambetova GK, Osmanov A, Denning DW.

J Fungi (Basel). 2019 Jul 19;5(3). pii: E66. doi: 10.3390/jof5030066.

7.

The Burden of Serious Fungal Infections in Tajikistan.

Bobokhojaev OI, Osmanov A, Aliev SP, Radjabzoda AS, Avgonov ZT, Manonov ST, Denning DW.

J Fungi (Basel). 2019 Jul 21;5(3). pii: E68. doi: 10.3390/jof5030068.

8.

Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.

García-Moreno J, Melendo-Pérez S, Martín-Gómez MT, Frick MA, Balcells-Ramírez J, Pujol-Jover M, Martín-Nalda A, Mendoza-Palomar N, Soler-Palacín P.

Enferm Infecc Microbiol Clin. 2019 Jul 1. pii: S0213-005X(19)30187-9. doi: 10.1016/j.eimc.2019.05.005. [Epub ahead of print] English, Spanish.

PMID:
31272810
9.

Absence of cutaneous involvement in disseminated Talaromyces marneffei infection in an AIDS patient: a case report and literature review.

Pongpech N, Rotjanapan P.

Infect Drug Resist. 2019 Jun 4;12:1493-1499. doi: 10.2147/IDR.S207819. eCollection 2019.

10.

Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients.

Liu CJ, Lee TF, Ruan SY, Yu CJ, Chien JY, Hsueh PR.

Infect Drug Resist. 2019 May 30;12:1457-1467. doi: 10.2147/IDR.S199761. eCollection 2019.

11.

Sudden, Sharp Turn in an AIDS Patient's Course Following the Onset of Fulminant Type 1 Diabetes.

Shimoyama Y, Umegaki O, Ooi Y, Shigemoto S, Agui T, Kadono N, Minami T.

Acta Med Okayama. 2019 Jun;73(3):263-267. doi: 10.18926/AMO/56870.

12.

Histoplasma capsulatum and Pneumocystis jirovecii coinfection in hospitalized HIV and non-HIV patients from a tertiary care hospital in Mexico.

Carreto-Binaghi LE, Morales-Villarreal FR, García-de la Torre G, Vite-Garín T, Ramirez JA, Aliouat EM, Martínez-Orozco JA, Taylor ML.

Int J Infect Dis. 2019 Sep;86:65-72. doi: 10.1016/j.ijid.2019.06.010. Epub 2019 Jun 15.

13.

A rare case of an HIV-seronegative AIDS patient with Pneumocystis jirovecii pneumonia.

Yan S, Huang J, Zheng Q, Zhu H, Gao Z, Feng J, Xu Y.

BMC Infect Dis. 2019 Jun 14;19(1):525. doi: 10.1186/s12879-019-4143-8.

14.

Serial change in serum biomarkers during treatment of Non-HIV Pneumocystis pneumonia.

Urabe N, Sakamoto S, Sano G, Ito A, Sekiguchi R, Homma S.

J Infect Chemother. 2019 Jun 8. pii: S1341-321X(19)30139-4. doi: 10.1016/j.jiac.2019.05.007. [Epub ahead of print]

PMID:
31186197
15.

Pneumocystis jirovecii pneumonia at chest High-resolution Computed Tomography (HRCT) in non-HIV immunocompromised patients: Spectrum of findings and mimickers.

Cereser L, Dallorto A, Candoni A, Volpetti S, Righi E, Zuiani C, Girometti R.

Eur J Radiol. 2019 Jul;116:116-127. doi: 10.1016/j.ejrad.2019.04.025. Epub 2019 May 1. Review.

PMID:
31153552
16.

Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients.

Guegan H, Robert-Gangneux F.

Curr Opin Infect Dis. 2019 Aug;32(4):314-321. doi: 10.1097/QCO.0000000000000559.

PMID:
31107250
17.

Late Onset of Antiretroviral Therapy in Adults Living with HIV in an Urban Area in Brazil: Prevalence and Risk Factors.

Pacheco PRG, Zara ALSA, Silva E Souza LC, Turchi MD.

J Trop Med. 2019 Apr 7;2019:5165313. doi: 10.1155/2019/5165313. eCollection 2019.

18.

HIV/AIDS length of stay in Portugal under financial constraints: a longitudinal study for public hospitals, 2009-2014.

Augusto GF, Dias SS, Abrantes AV, Martins MRO.

BMC Health Serv Res. 2019 May 10;19(1):303. doi: 10.1186/s12913-019-4131-0.

19.

Pneumocystosis pneumonia: A comparison study between HIV and non-HIV immunocompromised patients.

Rego de Figueiredo I, Vieira Alves R, Drummond Borges D, Torres M, Lourenço F, Antunes AM, Gruner H, Panarra A.

Pulmonology. 2019 Sep - Oct;25(5):271-274. doi: 10.1016/j.pulmoe.2019.04.003. Epub 2019 May 7.

20.

Detection of Pneumocystis jirovecii by quantitative real-time PCR in oral rinses from Pneumocystis pneumonia asymptomatic human immunodeficiency virus patients.

Fraczek MG, Ahmad S, Richardson M, Kirwan M, Bowyer P, Denning DW, Rautemaa R.

J Mycol Med. 2019 Jun;29(2):107-111. doi: 10.1016/j.mycmed.2019.04.001. Epub 2019 Apr 30.

PMID:
31047784

Supplemental Content

Loading ...
Support Center